Zhengqiang Wang

26PUBLICATIONS
35CO-AUTHORS
Medical virologyProteins and peptidesPharmaceutical delivery technologiesToxicology (incl. clinical toxicology)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 24, 2026
3-Hydroxypyrimidine-2,4-dione derivatives as monkeypox virus resolvase (Mpr) inhibitors.

|Jun 18, 2026
Discovery and characterization of a hydroxypyridone-3-carboxamide analog as an antiviral lead against orthopoxviruses.

|Mar 27, 2026
Damaging the conical morphology of HIV-1 capsid by targeting the FG-binding pocket and disfavoring pentameric subunits needed for core closure.

William M McFadden, Karen A Kirby, Zachary C Lorson

|Jan 09, 2026
Design, synthesis and profiling of highly potent antivirals targeting emerging drug-resistant HIV-1 variants.

Nicolas Jamey, D M Nirosh Udayanga, Huanchun Zhang

|Jan 09, 2026
Structural, biophysical, and virological mechanistic characterization of HIV-1 capsid-targeting antivirals.

Karen A Kirby, William M McFadden, Lei Wang

|Dec 22, 2025
1-Hydroxy-1,8-napthyridinone (DHN) Analogs Potently Inhibit Monkeypox Virus Resolvase (Mpr).

Samuel Offei, Jacob P Mahoney, Ziyue Wang

Pageof 5

Frequent Collaborators

6 joint publications

Karen A Kirby

5 joint publications

Stefan G Sarafianos

4 joint publications

Philip R Tedbury

4 joint publications

Jacob P Mahoney